Klinične študije za Migrena v Ohio
13 študij za Migrena išče udeležence na lokacijah v Ohio.
Mesta v Ohio
Uradno besedilo študije (angleško)
Study of EVO756 in Adults With Migraine
- NeuroScience Research Center, Canton
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevFaza 1
Starost 6–11 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Childrens, Columbus
Vključevanje udeležencev
Starost 10–17 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Ohio State University Wexner Medical Center, Columbus
Vključevanje udeležencevFaza 4
Starost 18–70 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
- University Of Cincinnati Medical Center /ID# 231199, Cincinnati
- Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
- in še 3
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Hometown Research, Columbus
- Hometown Research, Milford
- CincyScience, West Chester
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT05987592A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center - PIN, Cincinnati
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT05164172Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #4, Cincinnati
Vključevanje udeležencevFaza 4
Starost 6–11 · Vsi spoli · Posodobljeno 27. jan. 2025 · NCT04748601Overlapping Pain Trajectory Study
- Cincinnati Children's Hospital, Cincinnati
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 10–19 · Vsi spoli · Posodobljeno 22. avg. 2024 · NCT05752396Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.